OOIR: Observatory of International Research

Papers

(The H4-Index of Advanced Drug Delivery Reviews is 85. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Editorial board members	1059
Emerging antibiotic alternatives: From antimicrobial peptides to bacteriophage therapies	388
Recent advances in endocrine organoids for therapeutic application	317
Gene editing strategies to treat lysosomal disorders: The example of mucopolysaccharidoses	291
Design, development and clinical translation of CriPec®-based core-crosslinked polymeric micelles	258
Advances in lung-on-a-chip platforms for nanotherapeutic evaluation and screening	254
Protein-based nanocarriers in the management of hard-to-treat solid tumours	248
Bacterially mediated drug delivery and therapeutics: Strategies and advancements	237
Cell membrane-coated nanoparticles for targeting carcinogenic bacteria	229
Emerging strategies to bypass transplant rejection via biomaterial-assisted immunoengineering: Insights from islets and beyond	221
Covalent chemistry in targeted protein degradation	210
On-Chip modeling of drug-gut interactions in Oral drug delivery	210
Liposomal formulations for treating lysosomal storage disorders	207
Integrating microneedles and sensing strategies for diagnostic and monitoring applications: The state of the art	206
Opportunities and challenges in delivering biologics for Alzheimer’s disease by low-intensity ultrasound	194
Nanoparticle-neutrophils interactions for autoimmune regulation	190
MIDD in Japan– Implementations, challenges and opportunities	188
Penetration and translocation of functional inorganic nanomaterials into biological barriers	187
Progress on the pathological tissue microenvironment barrier-modulated nanomedicine	176
Polymer-based drug delivery systems under investigation for enzyme replacement and other therapies of lysosomal storage disorders	174
Models to study basic and applied aspects of lysosomal storage disorders	171
In vitro models of the interplay between glioblastoma and blood–brain barrier for stratifying drug efficacy	170
Genome-scale metabolic modelling in antimicrobial pharmacology: Present and future	164
Luminescent quantum dots: Synthesis, optical properties, bioimaging and toxicity	157
Long-acting inhaled medicines: Present and future	154

Editorial Board	152
Editorial Board	151
Targeting microbiome, drug metabolism, and drug delivery in oncology	147
Emerging Voices in Drug Delivery – Harnessing and Modulating Complex Biological Systems (Issue 2)	147
iPSC-derived T cells and macrophages: Manufacturing and next-generation application approaches	145
Red to near-infrared carbon dots: synthesis, cellular interactions, drug loading, and therapeutic applications	145
Protein encapsulation of nanocatalysts: A feasible approach to facilitate catalytic theranostics	144
Biomarker and therapeutic potential of peripheral extracellular vesicles in Alzheimer’s disease	143
Activatable dual-functional molecular agents for imaging-guided cancer therapy	142
Synthetic biology-guided design and biosynthesis of protein polymers for delivery	135
Activatable fluorescent probes for real-time imaging-guided tumor therapy	132
Nanoparticles-mediated ion channels manipulation: From their membrane interactions to bioapplications	128
Quality by Computational Design: Harnessing AI to Advance Rational Drug Development	124
3D printing of drug delivery systems enhanced with micro/nano-technology	124
Exosome- and extracellular vesicle-based approaches for the treatment of lysosomal storage disorders	123
In situ cellular hitchhiking of nanoparticles for drug delivery	122
From molecule to absorption: a multiscale framework for subcutaneous biologic delivery	121
Novel strategies for modulating the gut microbiome for cancer therapy	120
From cells to subcellular organelles: Next-generation cancer therapy based on peptide self-assembly	119
Solid implantable devices for sustained drug delivery	119
Small data, big challenges: Machine- and deep-learning strategies for data-limited drug discovery	118
Drug delivery using gold nanoparticles	116
Biopharmaceutical drug delivery and phototherapy using protein crystals	115
Strategies to develop polymeric microneedles for controlled drug release	115
RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer	115
Hydrogen sulfide in cancer therapy: Intelligent delivery platforms and synergistic therapeutic paradigms	113
Convection-enhanced delivery for brain malignancies: Technical parameters, formulation strategies and clinical perspectives	113
Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies	112
Novel drug delivery systems for the management of dry eye	111
Matrix-integrated microfluidic tumor models for evaluating drug delivery systems and pre-clinical testing	107
Emerging drug delivery systems with traditional routes – A roadmap to chronic inflammatory diseases	105
Lysosomal therapies and drug delivery strategies: An overview	105
Nanobodies: Robust miniprotein binders in biomedicine	105
Hurdles in translating science from lab to market in delivery systems for Cosmetics: An industrial perspective	104
Soft nano and microstructures for the photomodulation of cellular signaling and behavior	99
Advances in photoactivated carbon-based nanostructured materials for targeted cancer therapy	99
Antibody-drug conjugates as multimodal therapies against hard-to-treat cancers	98
Technology for Nucleic Acid Delivery in the Treatment of Hematological Malignancies	98
Tumor microenvironment subtyping in pancreatic ductal adenocarcinoma: New avenues for personalized therapeutic strategies	98
Therapeutic gases as emerging treatments for oral diseases	98
Light sheet fluorescence microscopy for monitoring drug delivery: Unlocking the developmental phases of embryos	98
Miniaturized therapeutic systems for ultrasound-modulated drug delivery to the central and peripheral nervous system	97
Nanosensitizer-mediated unique dynamic therapy tactics for effective inhibition of deep tumors	97
Unignored intracellular journey and biomedical applications of extracellular vesicles	97
Fit and forget: The future of dental implant therapy via nanotechnology	96
Lipid nanoparticles for targeted delivery of anticancer therapeutics: Recent advances in development of siRNA and lipoprotein-mimicking nanocarriers	95
Tumour extravasation of nanomedicine: The EPR and alternative pathways	95
Preface: Image-assisted organoid research and application	94
Model-informed precision dosing: State of the art and future perspectives	94
Harnessing reactive oxygen species for precision medicine: ROS-Activatable PROTACs for lung Cancer	93

Corrigendum to “Editorial: Advanced strategies to bridge the gap between inflammation and tissue regeneration” [Adv. Drug Deliv. Rev. 209 (2024) 115328]	93
Editorial Board	92
Editorial Board	90
Gelatin-integrated carbon nanomaterials in nanomedicine: From biosensing and bioprinting to tissue engineering and other biomedical applications	89
Oral nanomedicine biointeractions in the gastrointestinal tract in health and disease	89
MicroRNA-targeting nanomedicines for the treatment of intervertebral disc degeneration	88
Engineering tissue patterning in human stem cell-based embryo models	88
Design of disintegrable nanoassemblies to release multiple small-sized nanoparticles	87
Microfluidic reactors for the synthesis of inorganic and hybrid nanoparticles for drug delivery	87
Nanoparticle-based immunotherapeutics: From the properties of nanocores to the differential effects of administration routes	86
Recent progress in upconversion nanomaterials for emerging optical biological applications	85
Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy	85